Skip to main content
. 2016 Nov 11;113(48):E7759–E7768. doi: 10.1073/pnas.1609376113

Fig. 7.

Fig. 7.

Neoantigen expression in CTNNB1/PTEN altered inflamed and noninflamed patient cohorts. (A) The overall number of NSSMs is presented per HLA-A*0201 tumor, among the inflamed and noninflamed cohorts separated into CTNNB1/PTEN altered and unknown alterations (no alterations). (B and C) The number of identified candidate (B) and predicted high-binding (C) HLA-A*0201 binding peptides are plotted for CTNNB1/PTEN altered and nonaltered, inflamed and noninflamed cohorts. One-way ANOVA was used to determine significance; shown are boxplots with a 0.05 confidence interval.